Your browser doesn't support javascript.
loading
Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study.
Gogtay, Nithya J; Munshi, Renuka; Ashwath Narayana, D H; Mahendra, B J; Kshirsagar, Vikas; Gunale, Bhagwat; Moore, Susan; Cheslock, Peter; Thaker, Saket; Deshpande, Siddharth; Karande, Sunil; Kumbhar, Dipti; Ravish, H S; Harish, B R; Pisal, Sambhaji S; Dhere, Rajeev; Parulekar, Varsha; Blackwelder, William C; Molrine, Deborah C; Kulkarni, Prasad S.
Afiliación
  • Gogtay NJ; Department of Clinical Pharmacology, KEM Hospital and Seth G. S. Medical College, Mumbai, Maharashtra.
  • Munshi R; Department of Clinical Pharmacology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra.
  • Ashwath Narayana DH; Department of Community Medicine, Kempegowda Institute of Medical Sciences, Bengaluru.
  • Mahendra BJ; Department of Community Medicine, Mandya Institute of Medical Sciences, Karnataka.
  • Kshirsagar V; Department of Preventive and Social Medicine (Community Medicine), B. J. Government Medical College and Sassoon General Hospitals.
  • Gunale B; Serum Institute of India Pvt Ltd, Pune, Maharashtra, India.
  • Moore S; Rabies Laboratory, Kansas State University, Manhattan.
  • Cheslock P; MassBiologics, University of Massachusetts Medical School, Boston.
  • Thaker S; Department of Clinical Pharmacology, KEM Hospital and Seth G. S. Medical College, Mumbai, Maharashtra.
  • Deshpande S; Department of Clinical Pharmacology, KEM Hospital and Seth G. S. Medical College, Mumbai, Maharashtra.
  • Karande S; Department of Pediatrics, KEM Hospital and Seth G. S. Medical College.
  • Kumbhar D; Department of Clinical Pharmacology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra.
  • Ravish HS; Department of Community Medicine, Kempegowda Institute of Medical Sciences, Bengaluru.
  • Harish BR; Department of Community Medicine, Mandya Institute of Medical Sciences, Karnataka.
  • Pisal SS; Serum Institute of India Pvt Ltd, Pune, Maharashtra, India.
  • Dhere R; Serum Institute of India Pvt Ltd, Pune, Maharashtra, India.
  • Parulekar V; DiagnoSearch Life Sciences Pvt Ltd, Thane, Maharashtra, India.
  • Blackwelder WC; School of Medicine, University of Maryland-Baltimore.
  • Molrine DC; MassBiologics, University of Massachusetts Medical School, Boston.
  • Kulkarni PS; Serum Institute of India Pvt Ltd, Pune, Maharashtra, India.
Clin Infect Dis ; 66(3): 387-395, 2018 01 18.
Article en En | MEDLINE | ID: mdl-29020321
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rabia / Anticuerpos Neutralizantes / Profilaxis Posexposición / Anticuerpos Monoclonales / Anticuerpos Antivirales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rabia / Anticuerpos Neutralizantes / Profilaxis Posexposición / Anticuerpos Monoclonales / Anticuerpos Antivirales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article